Catalent provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The company was founded in 2007 and is founded in Somerset, New Jersey.
CTLT Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for CTLT, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Catalent Inc ranked in the 4th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Catalent Inc, consider:
The company's compound free cash flow growth rate over the past 5.18 years comes in at -0.06%; that's greater than merely 17.65% of US stocks we're applying DCF forecasting to.
The weighted average cost of capital for the company is 9. This value is greater than merely 23.83% stocks in the Healthcare sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CTLT, try STAA, AGHC, ALC, AMRN, and ATRS.
Biotherapeutic drug products encompass various active substances. These substances are either produced or extracted from biological sources. These biotherapeutic drug therapy products are obtained from various recombinant DNA technologies such as interleukins, interferons, etc. There are various advantages of these
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, today announced that it will release financial results for the second quarter of fiscal year 2021 ended December 31, 2020, before the market open on Tuesday, February 2, 2021. The Company’s management will host a webcast to discuss the results at 8:15 a.m. ET on the same day.
Clinical trials are research studies performed in a group of people called sample that are aimed at evaluating a medical, surgical, or behavioral intervention. It is a primary way for researchers to measure safety, efficacy, side effects and positive effects